Original Research
Published on 30 Jul 2024
Improving the response to lenvatinib in partial responders using a Constrained-Disorder-Principle-based second-generation artificial intelligence-therapeutic regimen: a proof-of-concept open-labeled clinical trial
in Head and Neck Cancer
- 1,653 views
- 8 citations